THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW

ABSTRACT Background: Bile acids (BAs) are steroid molecules synthesized exclusively in the liver, being end products of cholesterol catabolism. BAs are known to be involved in several metabolic alterations, including metabolic syndrome and type 2 diabetes mellitus (DM2). DM2 is a chronic degenerati...

Full description

Bibliographic Details
Main Authors: Luis Jesuino de Oliveira ANDRADE, Gabriela Correia Matos de OLIVEIRA, Luis Matos de OLIVEIRA
Format: Article
Language:English
Published: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE) 2023-11-01
Series:Arquivos de Gastroenterologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032023000400536&lng=en&tlng=en
_version_ 1797449368925634560
author Luis Jesuino de Oliveira ANDRADE
Gabriela Correia Matos de OLIVEIRA
Luis Matos de OLIVEIRA
author_facet Luis Jesuino de Oliveira ANDRADE
Gabriela Correia Matos de OLIVEIRA
Luis Matos de OLIVEIRA
author_sort Luis Jesuino de Oliveira ANDRADE
collection DOAJ
description ABSTRACT Background: Bile acids (BAs) are steroid molecules synthesized exclusively in the liver, being end products of cholesterol catabolism. BAs are known to be involved in several metabolic alterations, including metabolic syndrome and type 2 diabetes mellitus (DM2). DM2 is a chronic degenerative disease characterized by insulin resistance, insulin deficiency due to insufficient production of pancreatic ß-cells, and elevated serum glucose levels leading to multiple complications. Objective: The objective of this study is to investigate the role of BAs in the pathophysiology of DM2, highlighting the possibilities in the development of therapeutic procedures targeting BAs as an optional pathway in the treatment of DM2. Methods: The research was carried out through narrative review and publications on the relationship between BAs and DM2. The databases used for the search include PubMed, Scopus, and Web of Science. The keywords used for the search include bile acids, type 2 diabetes mellitus, metabolic syndrome, and metabolic disorders. Results: The studies have reported the involvement of BAs in the pathophysiology of DM2. BAs act as a ligand for the nuclear farnesoid X receptor, regulating glucose metabolism, lipid metabolism, and cellular energy production. Additionally, BAs modulate the production, elimination, and mobilization of BAs through the farnesoid X receptor. BAs also act as a signaling pathway through Takeda G protein-coupled receptor 5, further contributing to metabolic regulation. These findings suggest that targeting BAs may offer a novel therapeutic approach in the treatment of DM2. Conclusion: This study highlights the important role of BAs in DM2, specifically through their interactions with key metabolic pathways. Targeting BAs may represent an innovative and effective approach to the treatment of DM2.
first_indexed 2024-03-09T14:24:18Z
format Article
id doaj.art-ab2341d4b1cf48e6841eb54b54412b0f
institution Directory Open Access Journal
issn 1678-4219
language English
last_indexed 2024-03-09T14:24:18Z
publishDate 2023-11-01
publisher Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
record_format Article
series Arquivos de Gastroenterologia
spelling doaj.art-ab2341d4b1cf48e6841eb54b54412b0f2023-11-28T07:48:47ZengInstituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)Arquivos de Gastroenterologia1678-42192023-11-0160453654210.1590/s0004-2803.230402023-86THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEWLuis Jesuino de Oliveira ANDRADEhttps://orcid.org/0000-0002-7714-0330Gabriela Correia Matos de OLIVEIRAhttps://orcid.org/0000-0002-8042-0261Luis Matos de OLIVEIRAhttps://orcid.org/0000-0003-4854-6910ABSTRACT Background: Bile acids (BAs) are steroid molecules synthesized exclusively in the liver, being end products of cholesterol catabolism. BAs are known to be involved in several metabolic alterations, including metabolic syndrome and type 2 diabetes mellitus (DM2). DM2 is a chronic degenerative disease characterized by insulin resistance, insulin deficiency due to insufficient production of pancreatic ß-cells, and elevated serum glucose levels leading to multiple complications. Objective: The objective of this study is to investigate the role of BAs in the pathophysiology of DM2, highlighting the possibilities in the development of therapeutic procedures targeting BAs as an optional pathway in the treatment of DM2. Methods: The research was carried out through narrative review and publications on the relationship between BAs and DM2. The databases used for the search include PubMed, Scopus, and Web of Science. The keywords used for the search include bile acids, type 2 diabetes mellitus, metabolic syndrome, and metabolic disorders. Results: The studies have reported the involvement of BAs in the pathophysiology of DM2. BAs act as a ligand for the nuclear farnesoid X receptor, regulating glucose metabolism, lipid metabolism, and cellular energy production. Additionally, BAs modulate the production, elimination, and mobilization of BAs through the farnesoid X receptor. BAs also act as a signaling pathway through Takeda G protein-coupled receptor 5, further contributing to metabolic regulation. These findings suggest that targeting BAs may offer a novel therapeutic approach in the treatment of DM2. Conclusion: This study highlights the important role of BAs in DM2, specifically through their interactions with key metabolic pathways. Targeting BAs may represent an innovative and effective approach to the treatment of DM2.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032023000400536&lng=en&tlng=enBile Acidshepatobiliary dysfunctionfarnesoid X receptorTakeda G protein-coupled receptor 5type 2 diabetes mellitus
spellingShingle Luis Jesuino de Oliveira ANDRADE
Gabriela Correia Matos de OLIVEIRA
Luis Matos de OLIVEIRA
THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW
Arquivos de Gastroenterologia
Bile Acids
hepatobiliary dysfunction
farnesoid X receptor
Takeda G protein-coupled receptor 5
type 2 diabetes mellitus
title THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW
title_full THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW
title_fullStr THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW
title_full_unstemmed THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW
title_short THE CONNECTION BETWEEN BILE ACIDS AND TYPE 2 DIABETES MELLITUS - A REVIEW
title_sort connection between bile acids and type 2 diabetes mellitus a review
topic Bile Acids
hepatobiliary dysfunction
farnesoid X receptor
Takeda G protein-coupled receptor 5
type 2 diabetes mellitus
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032023000400536&lng=en&tlng=en
work_keys_str_mv AT luisjesuinodeoliveiraandrade theconnectionbetweenbileacidsandtype2diabetesmellitusareview
AT gabrielacorreiamatosdeoliveira theconnectionbetweenbileacidsandtype2diabetesmellitusareview
AT luismatosdeoliveira theconnectionbetweenbileacidsandtype2diabetesmellitusareview
AT luisjesuinodeoliveiraandrade connectionbetweenbileacidsandtype2diabetesmellitusareview
AT gabrielacorreiamatosdeoliveira connectionbetweenbileacidsandtype2diabetesmellitusareview
AT luismatosdeoliveira connectionbetweenbileacidsandtype2diabetesmellitusareview